1. Home
  2. IVA vs SBFG Comparison

IVA vs SBFG Comparison

Compare IVA & SBFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVA
  • SBFG
  • Stock Information
  • Founded
  • IVA 2011
  • SBFG 1983
  • Country
  • IVA France
  • SBFG United States
  • Employees
  • IVA N/A
  • SBFG N/A
  • Industry
  • IVA Biotechnology: Pharmaceutical Preparations
  • SBFG Major Banks
  • Sector
  • IVA Health Care
  • SBFG Finance
  • Exchange
  • IVA Nasdaq
  • SBFG Nasdaq
  • Market Cap
  • IVA 162.8M
  • SBFG 155.9M
  • IPO Year
  • IVA 2020
  • SBFG N/A
  • Fundamental
  • Price
  • IVA $3.22
  • SBFG $18.87
  • Analyst Decision
  • IVA Strong Buy
  • SBFG
  • Analyst Count
  • IVA 4
  • SBFG 0
  • Target Price
  • IVA $13.25
  • SBFG N/A
  • AVG Volume (30 Days)
  • IVA 8.7K
  • SBFG 15.4K
  • Earning Date
  • IVA 03-26-2025
  • SBFG 04-17-2025
  • Dividend Yield
  • IVA N/A
  • SBFG 2.93%
  • EPS Growth
  • IVA N/A
  • SBFG N/A
  • EPS
  • IVA N/A
  • SBFG 1.72
  • Revenue
  • IVA $15,243,814.00
  • SBFG $56,774,000.00
  • Revenue This Year
  • IVA $18.05
  • SBFG N/A
  • Revenue Next Year
  • IVA $46.74
  • SBFG N/A
  • P/E Ratio
  • IVA N/A
  • SBFG $12.00
  • Revenue Growth
  • IVA N/A
  • SBFG 0.08
  • 52 Week Low
  • IVA $1.53
  • SBFG $13.01
  • 52 Week High
  • IVA $3.98
  • SBFG $24.48
  • Technical
  • Relative Strength Index (RSI)
  • IVA 50.87
  • SBFG 37.81
  • Support Level
  • IVA $2.88
  • SBFG $20.08
  • Resistance Level
  • IVA $3.10
  • SBFG $20.98
  • Average True Range (ATR)
  • IVA 0.22
  • SBFG 0.59
  • MACD
  • IVA -0.01
  • SBFG 0.03
  • Stochastic Oscillator
  • IVA 30.37
  • SBFG 22.54

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

About SBFG SB Financial Group Inc.

SB Financial Group Inc operates as a Holding Company of State Bank and RDSI/DCM. Its activities involve commercial banking, trust, and financial services. It offers a full-range of financial services for consumers and small businesses, including trust services, mortgage banking, wealth management services, commercial and agricultural lending. It accepts deposits, such as checking accounts, savings accounts, money market accounts, demand deposits, and time certificates of deposit. It earns revenue in the form of interest income.

Share on Social Networks: